Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20194172 20178793 1.84 56.8 null 2018-01-09 2018-01-31 CISPLATIN + TEYSUNO 02 N CISPLATIN + RT 100352389
20194533 20178794 1.75 null null 2018-01-16 2018-01-16 FCR Oral - Cycle 2 onwards N null BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE 100062470
20197298 20178795 1.8 71 null 2021-03-31 2021-03-31 MITOMYCIN 02 null PALBOCICLIB 101227674
20198126 20178798 1.65 97 Palliative (P) 2021-02-15 2021-02-15 CARBOPLATIN + RT 02 null FOCUS4 TRIAL 100341536
20198192 20178799 1.92 96.9 Palliative (P) 2019-11-01 2019-11-03 IBRUTINIB 02 null COSMIC TRIAL 100980667
20199648 20178800 1.57 81.3 Palliative (P) 2021-03-12 2021-03-12 Fulvestrant + Palbociclib 02 null CAP + RT 100122884
20199729 20178801 1.62 91 Palliative (P) 2020-08-11 2020-08-12 Cetuximab +Cisplatin + FU (Cycle 1) 02 N BORTEZOMIB + THALIDOMIDE 100995507
20200823 20178802 1.71 92.2 Palliative (P) 2014-01-16 2018-11-29 Procarbazine null N DASATINIB 100337471
20201314 20178804 1.86 51.1 Curative (C) 2018-05-02 2018-11-06 Cabazitaxel 02 N ECF 101256435
20203204 20178805 1.79 69.7 Palliative (P) 2021-02-12 2021-02-21 CABOZANTINIB 02 N CARBOPLATIN + VINORELBINE 101602500
20203627 20178806 1.81 63.7 Palliative (P) 2022-05-21 2022-05-27 SCOPE 2 TRIAL 02 N CYCLOPHOSPHAMIDE + EPIRUBICIN 101042890
20204423 20178808 1.51 68 Palliative (P) 2022-01-06 2022-01-06 ECarboX 02 N ACELARATE TRIAL 100383333
20206048 20178812 1.77 65.8 Curative (C) 2019-12-29 2019-12-29 CISPLATIN + FLUOROURACIL + Trastuzumab 02 null PHITT D2 CARBOPLATIN / ETOPOSIDE 101257517
20206119 20178813 1.8 60 null 2018-03-01 2018-03-01 Bevacizumab + FLUOROURACIL + IRINOTECAN 02 null CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE 100637538
20206443 20178814 1.74 80.2 null 2018-12-26 2019-01-05 ARISTOTLE TRIAL 02 N CARBOPLATIN + RALTITREXED 101450822
20206480 20178815 1.6 111 Palliative (P) null 2018-08-28 FOCUS4 TRIAL 02 N TOPOTECAN 100364677
20206530 20178816 1.55 73.2 Curative (C) 2019-08-14 2019-08-18 EEF or EOF 02 null BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN 101395576
20206644 20178817 1.65 60.5 Palliative (P) 2020-01-06 2020-01-06 BENDAMUSTINE 02 N RITUXIMAB 101417379
20207941 20178818 null null null 2020-01-27 2020-07-16 Pertuzumab 02 N BORTEZOMIB + THALIDOMIDE 100556932
20208403 20178819 1.82 57.2 null 2022-04-03 2022-05-02 null 02 null FLUOROURACIL + INTERFERON ALFA 101228832
20208450 20178820 1.69 69.9 Palliative (P) 2020-11-24 2020-12-21 Docetaxel+Gemcitabine (no prior RT) 02 N CISPLATIN + IFOSFAMIDE + MITOMYCIN 101828578
20211578 20178823 1.58 59 Palliative (P) 2021-09-01 2021-09-11 Cisplatin + Fluorouracil + RT 5day 02 N PLATO TRIAL 100774675
20212294 20178824 1.79 68.6 Curative (C) 2019-09-22 2019-12-25 EOF 02 null BEVACIZUMAB + CAPECITABINE + OXALIPLATIN 100988487
20213191 20178826 1.58 115.9 03 2021-11-15 2022-01-21 FCiSt 02 N TEMOZOLOMIDE 101484197
20214103 20178827 1.53 95.55 Palliative (P) 2017-06-28 2017-06-28 SCOPE 1 TRIAL 02 N DABRAFENIB + TRAMETINIB 100473129
20214585 20178828 1.73 47 null 2018-08-14 2018-08-19 ECarboX 02 N INTERAACT TRIAL 100678103
20215650 20178831 1.61 102 03 2020-09-05 2020-09-05 Pazopanib 02 null CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 100892795
20215936 20178832 1.8 62.9 null 2019-12-23 2019-12-29 CT7001 02 null CAPECITABINE + CISPLATIN + STREPTOZOCIN 101630201
20216542 20178833 1.69 86.6 null 2021-09-08 2021-09-18 null 02 null INTERAACT TRIAL 100867680
20217411 20178836 1.73 88.2 Curative (C) 2021-08-14 2021-08-18 Bevacizumab + CAPECITABINE + OXALIPLATIN 02 N CARBOPLATIN + VINORELBINE 101264157
20217473 20178837 1.83 98.4 null 2021-09-25 2021-11-01 Derazantinib 02 null EPIRUBICIN + FLUOROURACIL + OXALIPLATIN 101055865
20217550 20178838 0 115.9 Palliative (P) 2019-12-26 2019-12-28 Bortezomib + CYCLOPHOSPHAMIDE 2 null CABAZITAXEL 101585541
20218161 20178839 1.8 81 Palliative (P) 2019-10-24 2019-10-25 OXALIPLATIN + MDG + PANITUMUMAB 02 null CABAZITAXEL 100382991
20220087 20178840 1.57 92.5 Adjuvant (A) 2018-10-12 2018-11-23 Capecitabine + Streptozocin null N BORTEZOMIB + RITUXIMAB 100619517
20224829 20178842 1.86 18.9 Palliative (P) 2019-09-03 2019-09-10 Cabazitaxel 2 N ACTICCA-1 TRIAL 100465200
20018993 20178844 1.78 68 null 2021-12-23 2022-02-09 Bendamustine+Rituximab(Sub Courses) 02 null CARBOPLATIN + PEMETREXED 101406014
20021080 20178845 1.69 87 null 2020-03-22 2020-03-23 Rituximab N N CETUXIMAB + FLUOROURACIL 100564750
20033541 20178847 1.69 93.4 Curative (C) 2017-05-05 2017-09-08 AML 19 TRIAL 02 N CISPLATIN + FLUOROURACIL + RT 101695090
20035688 20178848 1.77 112 Curative (C) 2018-12-18 2019-01-12 Doxorubicin 20mg/m2 7 day 02 N IPILIMUMAB 100982369
20039998 20178849 1.87 62 null 2020-04-30 2020-07-08 Docetaxel + nintedanib 02 N IRINOTECAN + PANITUMUMAB + MDG 101839329
20046134 20178850 1.54 98.2 Curative (C) 2018-09-05 2018-10-07 CAV 01 N IRINOTECAN + MDG + PANITUMUMAB 100443890
20049933 20178851 1.52 87 Palliative (P) 2021-04-24 2021-12-24 TEMOZOLOMIDE 02 null IBRUTINIB 100460285
20051858 20178852 1.74 91.4 Palliative (P) 2017-10-24 2017-11-08 ACTICCA-1 Trial Y N ARISTOTLE TRIAL 101811196
20051949 20178853 1.8 66.3 Curative (C) 2021-11-03 2022-02-07 ECarboX 02 null CARBOPLATIN + PEMETREXED 100930921
20065293 20178855 1.86 84.9 Palliative (P) 2020-03-25 2020-03-25 CISPLATIN + FLUOROURACIL + RT 01 null BEVACIZUMAB + FLUOROURACIL + IRINOTECAN 100738854
20112612 20178857 1.65 59.6 Palliative (P) 2020-01-19 2020-01-22 Fluorouracil + Folinic + RT Bossett 02 Y INTERAACT TRIAL 101479073
20112952 20178858 1.69 55.7 Palliative (P) 2018-05-26 2018-07-08 PERTUZUMAB + TRASTUZUMAB 02 N CAPECITABINE + CETUXIMAB + OXALIPATIN 101726390
20199357 20178860 1.8 66.85 Palliative (P) 2019-11-26 2019-11-27 null 02 null OSIMERTINIB 100441603
20205619 20178861 1.75 68 null 2019-08-29 2019-09-19 Bevacizumab + FLUOROURACIL + IRINOTECAN 02 null ARISTOTLE TRIAL 101747743
20225316 20178862 1.58 67.8 Curative (C) 2018-05-21 2018-11-25 Encorafenib 01 N EC 101453265